SPADE Clinical Trial.

Purpose: This multicenter, prospective, single-arm phase 2 clinical trial aims to evaluate the safety, feasibility, and clinical outcomes of the SPADE operation (Spade-Shaped Anastomosis) in patients undergoing laparoscopic or robotic proximal gastrectomy for early gastric cancer located in the upper stomach . Background: While proximal gastrectomy (removing only the upper part of the stomach) offers nutritional advantages over total gastrectomy, it often leads to significant postoperative reflux esophagitis * The SPADE technique was developed to prevent this by creating an artificial anti-r

Trial Details

NCT ID
NCT07892183
Phase
NA
Sponsor
National Cancer Center, Korea
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Spade-Shaped Anastomosis after Laparoscopic or Robotic Proximal Gastrectomy Using Double Suture Anchoring between the Posterior Wall of the Esophagus and the Anterior Wall of the Stomac
Locations (sample)
  • Goyang, Gyeonggido, South Korea|36.21689,127.19731

Key Eligibility Criteria

  • ① Histologically confirmed diagnosis of gastric adenocarcinoma by biopsy.
  • Adult patients aged 20 years or older.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.
  • ④ American Society of Anesthesiologists (ASA) physical status classification of class I to III.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →